166 related articles for article (PubMed ID: 11335749)
1. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age.
Briët JM; van Wassenaer AG; Dekker FW; de Vijlder JJ; van Baar A; Kok JH
Pediatrics; 2001 Apr; 107(4):712-8. PubMed ID: 11335749
[TBL] [Abstract][Full Text] [Related]
2. Ten-year follow-up of children born at <30 weeks' gestational age supplemented with thyroxine in the neonatal period in a randomized, controlled trial.
van Wassenaer AG; Westera J; Houtzager BA; Kok JH
Pediatrics; 2005 Nov; 116(5):e613-8. PubMed ID: 16234230
[TBL] [Abstract][Full Text] [Related]
3. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation.
van Wassenaer AG; Kok JH; de Vijlder JJ; Briët JM; Smit BJ; Tamminga P; van Baar A; Dekker FW; Vulsma T
N Engl J Med; 1997 Jan; 336(1):21-6. PubMed ID: 8970936
[TBL] [Abstract][Full Text] [Related]
4. Free thyroxine levels during the first weeks of life and neurodevelopmental outcome until the age of 5 years in very preterm infants.
van Wassenaer AG; Briët JM; van Baar A; Smit BJ; Tamminga P; de Vijlder JJ; Kok JH
Pediatrics; 2002 Sep; 110(3):534-9. PubMed ID: 12205256
[TBL] [Abstract][Full Text] [Related]
5. Neurodevelopmental Outcomes at 42 Months After Thyroxine Supplementation in Infants Below 28 Weeks' Gestation: A Randomized Controlled Trial.
Ng SM; Turner MA; Weindling AM
Thyroid; 2020 Jul; 30(7):948-954. PubMed ID: 32070246
[No Abstract] [Full Text] [Related]
6. Thyroid function in very preterm newborns: possible implications.
Van Wassenaer AG; Kok JH; Briët JM; Pijning AM; de Vijlder JJ
Thyroid; 1999 Jan; 9(1):85-91. PubMed ID: 10037082
[TBL] [Abstract][Full Text] [Related]
7. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age.
Reuss ML; Paneth N; Pinto-Martin JA; Lorenz JM; Susser M
N Engl J Med; 1996 Mar; 334(13):821-7. PubMed ID: 8596548
[TBL] [Abstract][Full Text] [Related]
8. Thyroid function in preterm newborns; is T4 treatment required in infants < 27 weeks' gestational age?
Van Wassenaer AG; Kok JH; Briët JM; van Baar AL; de Vijlder JJ
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 4():12-8. PubMed ID: 9439908
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy.
Casey BM; Thom EA; Peaceman AM; Varner MW; Sorokin Y; Hirtz DG; Reddy UM; Wapner RJ; Thorp JM; Saade G; Tita AT; Rouse DJ; Sibai B; Iams JD; Mercer BM; Tolosa J; Caritis SN; VanDorsten JP;
N Engl J Med; 2017 Mar; 376(9):815-825. PubMed ID: 28249134
[TBL] [Abstract][Full Text] [Related]
10. An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks' gestation: results of the TIPIT trial.
Ng SM; Turner MA; Gamble C; Didi M; Victor S; Manning D; Settle P; Gupta R; Newland P; Weindling AM
Trials; 2013 Jul; 14():211. PubMed ID: 23841945
[TBL] [Abstract][Full Text] [Related]
11. Improving the outcome of infants born at <30 weeks' gestation--a randomized controlled trial of preventative care at home.
Spittle AJ; Ferretti C; Anderson PJ; Orton J; Eeles A; Bates L; Boyd RN; Inder TE; Doyle LW
BMC Pediatr; 2009 Dec; 9():73. PubMed ID: 19954550
[TBL] [Abstract][Full Text] [Related]
12. Increasing supplemental thyroid hormone use among premature infants born at 23 to 32 weeks' gestation.
Linn M; Yoder BA; Clark RH
Am J Perinatol; 2010 Oct; 27(9):731-5. PubMed ID: 20408110
[TBL] [Abstract][Full Text] [Related]
13. Follow-up outcomes at 1 and 2 years of infants born less than 32 weeks after Newborn Individualized Developmental Care and Assessment Program.
Maguire CM; Walther FJ; van Zwieten PH; Le Cessie S; Wit JM; Veen S
Pediatrics; 2009 Apr; 123(4):1081-7. PubMed ID: 19336365
[TBL] [Abstract][Full Text] [Related]
14. Postnatal thyroxine supplementation in infants less than 32 weeks' gestation: effects on pulmonary morbidity.
Smith LM; Leake RD; Berman N; Villanueva S; Brasel JA
J Perinatol; 2000; 20(7):427-31. PubMed ID: 11076326
[TBL] [Abstract][Full Text] [Related]
15. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study.
Pop VJ; Brouwers EP; Vader HL; Vulsma T; van Baar AL; de Vijlder JJ
Clin Endocrinol (Oxf); 2003 Sep; 59(3):282-8. PubMed ID: 12919150
[TBL] [Abstract][Full Text] [Related]
16. Motor nerve conduction velocity in very preterm infants in relation to L-thyroxine supplementation.
Smit BJ; Kok JH; de Vries LS; van Wassenaer AG; Dekker FW; Ongerboer de Visser BW
J Pediatr; 1998 Jan; 132(1):64-9. PubMed ID: 9470002
[TBL] [Abstract][Full Text] [Related]
17. Neurodevelopmental outcome at 2 years for preterm children born at 22 to 34 weeks' gestation in France in 2011: EPIPAGE-2 cohort study.
Pierrat V; Marchand-Martin L; Arnaud C; Kaminski M; Resche-Rigon M; Lebeaux C; Bodeau-Livinec F; Morgan AS; Goffinet F; Marret S; Ancel PY;
BMJ; 2017 Aug; 358():j3448. PubMed ID: 28814566
[No Abstract] [Full Text] [Related]
18. Thyroxine administration to infants of less than 30 weeks' gestational age does not increase plasma triiodothyronine concentrations.
van Wassenaer AG; Kok JH; Endert E; Vulsma T; de Vijlder JJ
Acta Endocrinol (Copenh); 1993 Aug; 129(2):139-46. PubMed ID: 8372599
[TBL] [Abstract][Full Text] [Related]
19. Somatosensory evoked potentials in very preterm infants in relation to L-thyroxine supplementation.
Smit BJ; Kok JH; de Vries LS; van Wassenaer AG; Dekker FW; Ongerboer de Visser BW
Pediatrics; 1998 May; 101(5):865-9. PubMed ID: 9565416
[TBL] [Abstract][Full Text] [Related]
20. Functioning at school age of moderately preterm children born at 32 to 36 weeks' gestational age.
van Baar AL; Vermaas J; Knots E; de Kleine MJ; Soons P
Pediatrics; 2009 Jul; 124(1):251-7. PubMed ID: 19564307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
